DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Selegiline Hydrochloride is a drug marketed by Apotex, Lannett Co Inc, Novitium Pharma, Rising, Apotex Inc, Boscogen, Chartwell Molecules, Cosette, G And W Labs Inc, I3 Pharms, Mylan, and Somerset. and is included in fourteen NDAs.
The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
A generic version of SELEGILINE HYDROCHLORIDE was approved as selegiline hydrochloride by APOTEX INC on June 6th, 1997.
Recent Clinical Trials for SELEGILINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|E-Group ICT Software Informatikai Zrt.||Phase 2|
|László Mangel||Phase 2|
|University of Oxford||N/A|